 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Selenium in Treating Patients With Adenomatous Colorectal Polyps
|
|
|
|
Phase III
|
|
|
|
UARIZ-00-0430-01
UARIZ-HSC-00142, NCT00078897
|
|
| |
Chemoprevention of Colorectal Adenomas
|
|
|
|
Phase III
|
|
|
|
COLO CP-01-US
NCT00486512
|
|
| |
Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
|
|
|
|
Phase III
|
|
|
|
SWOG-S0000D
S0000D, SWOG-S0000D, NCT00706121
|
|
| |
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.
|
|
|
|
Phase II
|
|
|
|
MDA-ID-00109
NCI-P02-0219, N01-CN-95040, NCT00033371
|
|
| |
Curcumin for the Chemoprevention of Colorectal Cancer
|
|
|
|
Phase II
|
|
|
|
802193
NCT00118989
|
|
| |
Atorvastatin, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
|
|
|
|
Phase II
|
|
|
|
MAYO-030103
MAYO-1395-05, MAY03-1-03, NCT00335504
|
|
| |
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
|
|
|
|
Phase I
|
|
|
|
NU-NWU04-2-03
NWU04-2-03, NCT00468910
|
|
| |
Celecoxib in Treating Patients With Familial Adenomatous Polyposis
|
|
|
|
No phase specified
|
|
|
|
MDA-DM-02592
NCT00258219
|
|
| |
High Legume Diet in Preventing Cancer in Patients at High Risk for Recurrent Colorectal Cancer
|
|
|
|
No phase specified
|
|
|
|
NCI-05-C-N215
05-C-N215, NCT00339469
|
|
| |
Diet and Physical Activity in Healthy Overweight, Obese, or Inactive Participants at Risk of Developing Colorectal Cancer
|
|
|
|
No phase specified
|
|
|
|
VU-VICC-GI-0810
VICCGI0810, VU-VICC-061020, NCT00653484
|
|
